NeueHealth, Inc.: debt financing — NeueHealth secures $30M incremental term loan from NEA; issues penny warrants

NeueHealth, Inc.

Incremental term loan commitment of $30M from NEA lenders under existing credit agreement.
Issues warrants to purchase up to 1,113,563 shares of common stock at $0.01 per share.
Proceeds to support general corporate purposes and 2024 strategic priorities.
Audit Committee waived shareholder vote on warrant issuance, citing financial viability; NYSE approved exception.
NEA gains right to appoint one Board member after the 2024 annual meeting if certain thresholds met.

item 1.01 item 2.03 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

NeueHealth, Inc. incurred term loan of $30.0 million with NEA 18, New Enterprise Associates 17, L.P., New Enterprise Associates 16, L.P. and New Enterprise Associates 15, L.P..

Instrument: term loan
Principal: $30.0 million
Counterparty: NEA 18, New Enterprise Associates 17, L.P., New Enterprise Associates 16, L.P. and New Enterprise Associates 15, L.P.
Event: incurrence

Exact text from the filing

to date, and as amended by Incremental Amendment No. 2, the “Amended Credit Agreement”) to provide for a term loan commitment increase in an aggregate principal amount of $30.0 million (the “Commitment Increase”) by the NEA Lenders under the Amended Credit Agreement. Loans under the Commitment Increase will have the same terms as loans under the original term

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

NeueHealth, Inc. amended Incremental Amendment No. 2 with NEA 18 Venture Growth Equity, L.P., New Enterprise Associates 17, L.P., New Enterprise Associates 16, L.P., New Enterprise Associates 15, L.P. valued at $30.0 million (effective 2024-04-08).

Action: amendment
Agreement: credit facility
Counterparty: NEA 18 Venture Growth Equity, L.P., New Enterprise Associates 17, L.P., New Enterprise Associates 16, L.P., New Enterprise Associates 15, L.P.
Value: $30.0 million
Effective: 2024-04-08

Exact text from the filing

On April 8, 2024, (i) NeueHealth, Inc. (the “Company”) and (ii) NEA 18 Venture Growth Equity, L.P. (“NEA 18”), New Enterprise Associates 17, L.P., New Enterprise Associates 16, L.P. and New Enterprise Associates 15, L.P. (collectively, the “NEA Lenders”) entered into Incremental Amendment No. 2 (“Incremental Amendment No. 2”) to the Credit Agreement, dated as of August 4, 2023, between the Company and NEA 18 (as amended to date, and as amended by Incremental Amendment No. 2, the “Amended Credit Agreement”) to provide for a term loan commitment increase in an aggregate principal amount of $30.0 million (the “Commitment Increase”) by the NEA Lenders under the Amended Credit Agreement.

View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

Source: SEC EDGAR

accession 0001628280-24-015545

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.